Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Accrual, Publication Bias, and the Coronavirus in 2020
4
Zitationen
1
Autoren
2020
Jahr
Abstract
The era of COVID19 reflects the importance, perhaps now more than ever, of transparency in the outcomes of trials small and large. The Oncologist Clinical Trial Results (CTR) section has endeavored to provide a remedy for the persistent problem of underreporting in clinical trials in oncology and the subsequent publication bias that this practice necessarily creates. As The Oncologist celebrates its 25th Anniversary, we focus not only on the ethical and moral imperatives behind CTR, but also on the practical goal of informing the practice of treating physicians.
Ähnliche Arbeiten
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 · 33.756 Zit.
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
2020 · 18.650 Zit.
To Err Is Human
2000 · 14.081 Zit.
Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 · 9.667 Zit.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
2024 · 6.957 Zit.